Skip to main content
Clinical Trials/NCT04020770
NCT04020770
Completed
Not Applicable

Influence of Upper Extremity Vibration on Spasticity and Function in Persons With Tetraplegia

Shepherd Center, Atlanta GA1 site in 1 country12 target enrollmentOctober 28, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Spinal Cord Injuries
Sponsor
Shepherd Center, Atlanta GA
Enrollment
12
Locations
1
Primary Endpoint
Satisfaction and Adherence Questionnaire
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Vibration therapy is a possible alternative to drug-based treatments for spasticity following SCI. Research indicates that it may provide temporary relief from spasticity, but many interventions under investigation are not portable and therefore access is limited. The aim of this study is to investigate the feasibility of using a portable vibrating device to decrease UE spasticity.

Registry
clinicaltrials.gov
Start Date
October 28, 2018
End Date
February 20, 2019
Last Updated
6 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Shepherd Center, Atlanta GA
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Have sustained cervical (neurological level C1-C8) SCI
  • Any ISNCSCI severity classification (A, B, C or D)
  • Have therapist-reported and self-reported spasticity in the arm or hand
  • Ability to pick up, move, and release at least one block (on the Box \& Blocks Test)
  • May participate if utilizing prescription medications, including baclofen pump for control of spasticity

Exclusion Criteria

  • Severe contractures of the arm/hand that limit passive movement of the elbow, wrist or fingers more than 50% of normal range of motion or presence of other orthopedic pathology that would adversely influence participation in the protocol
  • Any implanted catheter such as but not limited to CSF shunt, or the presence of pacemaker, implanted automatic internal cardioverter defibrillator (AICD, other cardiac implants and or conditions). Not including baclofen pump.
  • Severe pain or hypersensitivity of the arm/hand
  • Current pregnancy

Outcomes

Primary Outcomes

Satisfaction and Adherence Questionnaire

Time Frame: 20 minute delay post intervention

Self- report of satisfaction with and perceived ability to adhere to the intervention

Change in Modified Ashworth Scale from pre-intervention to post intervention, from pre intervention to 20 minute follow up, from post intervention to 20 minute follow up

Time Frame: Day 1

Clinical assessment of stretch-induced spasticity measured on a scale of 0-4 with 4 indicating the worst spasticity and 0 indicating no spasticity detectable upon clinical examination.

Change in Box and Blocks Test from pre-intervention to post intervention, from pre intervention to 20 minute follow up, from post intervention to 20 minute follow up

Time Frame: Day 1

Functional assessment of grasp and release

Change in Global Impression of Change Scale from pre-intervention to post intervention, from pre intervention to 20 minute follow up, from post intervention to 20 minute follow up

Time Frame: Day 1

Self-report of improvement or deterioration over time measured on a scale of 1-7 with 1 indicating very much improved and 7 indicating very much worse

Secondary Outcomes

  • Hand strength(Pre-intervention, immediately post-intervention, 20 minute delay post intervention)
  • Qualities of Spasticity Questionnaire(Baseline)
  • Pinch strength(Pre-intervention, immediately post-intervention, 20 minute delay post intervention)
  • Semmes-Weinstein Monofilament Test(Pre-intervention, immediately post-intervention, 20 minute delay post intervention)

Study Sites (1)

Loading locations...

Similar Trials